21 CFR § 821.50 - Availability.

---
identifier: "/us/cfr/t21/s821.50"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 821.50 - Availability."
title_number: 21
title_name: "Food and Drugs"
section_number: "821.50"
section_name: "Availability."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "H"
subchapter_name: "MEDICAL DEVICES"
part_number: "821"
part_name: "MEDICAL DEVICE TRACKING REQUIREMENTS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 331, 351, 352, 360, 360e, 360h, 360i, 371, 374."
regulatory_source: "58 FR 43447, Aug. 16, 1993, unless otherwise noted."
cfr_part: "821"
---


# 821.50 Availability.

(a) Manufacturers, distributors, multiple distributors, and final distributors shall, upon the presentation by an FDA representative of official credentials and the issuance of Form FDA 482 at the initiation of an inspection of an establishment or person under section 704 of the act, make each record and all information required to be collected and maintained under this part and all records and information related to the events and persons identified in such records available to FDA personnel.

(b) Records and information referenced in paragraph (a) of this section shall be available to FDA personnel for purposes of reviewing, copying, or any other use related to the enforcement of the act and this part. Records required to be kept by this part shall be kept in a centralized point for each manufacturer or distributor within the United States.

[58 FR 43447, Aug. 16, 1993, as amended at 65 FR 43690, July 14, 2000]